FDA Approved: LACRISERT — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved a supplemental application for LACRISERT (hydroxypropyl cellulose) from Bausch & Lomb Incorporated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• LACRISERT (hydroxypropyl cellulose)

Snippet

SUPPL AP for LACRISERT (HYDROXYPROPYL CELLULOSE)